Stay updated on Anifrolumab SubQ in Lupus Adults Clinical Trial
Sign up to get notified when there's something new on the Anifrolumab SubQ in Lupus Adults Clinical Trial page.

Latest updates to the Anifrolumab SubQ in Lupus Adults Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a small platform or display update without changing the underlying study record information.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded a Study Status section and updated the page revision to v3.5.2, replacing v3.5.0.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedAdded a 'Study Status' field in the record history and updated to version 44 (2026-03-18) with Revision v3.5.0; the prior entry for v3.4.3 was removed.SummaryDifference0.3%

- Check53 days agoChange DetectedA new revision entry v3.4.3 was added to the Record History and the previous v3.4.2 entry was removed.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded a new 'Study Status' column to the Record History to display current and past status updates for the study. An entry dated 2026-01-13 was removed.SummaryDifference0.2%

- Check74 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the Record History, with no change to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Anifrolumab SubQ in Lupus Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anifrolumab SubQ in Lupus Adults Clinical Trial page.